Î¥Ï€Î¿Ï ÏÎ³Î¹ÎºÎ® απόφαση

ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19089
H - ,
ATC / . DDD MON
( )
H01BA02 DESMOPRESSIN ACETATE
H01BA02 D 2201905 02 MINIRIN MELT ORAL.LYOP 60MCG/TAB BTx30 (BLIST 3x10 FERRING 0.0004 G 4.500 5.2867 23.79 23.71
H01BA02 D 2201906 01 MINIRIN MELT ORAL.LYOP 120MCG/TAB BTx30 (BLIST 3x10 FERRING 0.0004 G 9.000 5.2578 47.32 47.32
H01BB -
( )
H01BB02 OXYTOCIN SYNTHETIC
H01BB02 O 1910801 05 OXYTOCIN/GAP INJ.SOL 5 IU/ML AMP BTX2AMPSX1ML GAP A.E. 15 U 0.667 7.2714 4.85 4.85
H01BB03 CARBETOCIN
H01BB03 C 2706401 01 PABAL INJ.SOL 100MCG/ML BT x 5 AMPS x 1 M FERRING 0.0001 G 5.000 29.4200 147.10 59.20
H01C -
H01CB -
( )
H01CB02 OCTREOTIDE
H01CB02 O 1979801 01 SANDOSTATIN IN.SO.CR 0,1MG/ML AMP BTx5 AMPS NOVARTIS (HELLA 1 TE 5.000 4.5520 22.76 22.76
H01CB02 O 1979804 01 SANDOSTATIN IN.SO.CR 0,5MG/ML AMP BT x 5 AMPS x 1ML NOVARTIS (HELLA 1 TE 5.000 24.6220 123.11 70.41
H01CB02 O 2819701 01 SIROCTID INJ.SO.PFS 0,05MG/ML () BTx5 PF. SYR. ITF HELLAS A.E. 1 TE 5.000 1.8220 9.11 9.11
H01CB02 O 2819702 01 SIROCTID INJ.SO.PFS 0,1MG/ML () BTx5 PF. SYR. ITF HELLAS A.E. 1 TE 5.000 3.6400 18.20 18.20
H01CB02 O 2819703 01 SIROCTID INJ.SO.PFS 0,5MG/ML () BTx5 PF. SYR. ITF HELLAS A.E. 1 TE 5.000 19.6960 98.48 70.41
H01CB02 O 2819704 01 SIROCTID INJ.SOL 200MCG/ML () BTx1 VIALx5ML ITF HELLAS A.E. 1 TE 1.000 36.4100 36.41 14.08
H01CB G3 - /
( )
H01CB01 SOMATOSTATIN
H01CB01 S 2625101 01 ATOSTAN PS.SOL.INF 3 MG/VIAL BT x 1 VIAL + 1 AM 0.006 G 0.500 129.5800 64.79 60.39
H01CB01 S 2448901 01 EKLIVAN PD.SOL.INF 3MG/AMP BTx1 AMP+1 AMPx NOVENDIA 0.006 G 0.500 129.5800 64.79 60.39
H01CB01 S 2579301 01 SOMARITIN PS.SOL.INF 3MG/1ML AMP BTX1AMP+1AMPX 0.006 G 0.500 129.5800 64.79 60.39
H01CB01 S 2378402 02 SOMASTIN PS.INJ.SOL 3MG/VIAL BTx1VIAL+1BAGx2 ANGELINI PHARM 0.006 G 0.500 108.5800 54.29 54.29
H01CB01 S 2696001 01 SONAFRINE PS.SOL.INF 3MG/VIAL BTx1VIAL+1 AMP x TARGET PHARMA 0.006 G 0.500 129.5800 64.79 60.39